Vglut2 haploinsufficiency enhances behavioral sensitivity to MK-801 and amphetamine in mice. 2011

Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
Laboratory of Biological Psychology, Department of Psychology, University of Leuven, Tiensestraat 102, B-3000 Leuven, Belgium.

Recently developed mouse models have implicated the vesicular glutamate transporter 2 (VGLUT2) in psychostimulant-induced hyperactivity, a behavioral assay that is often applied to evaluate mouse behavior related to positive schizophrenia (SCZ) symptomatology. In present research, we wanted to evaluate further the role of subtle VGLUT2 impairment as a factor underlying SCZ symptomatology. To this end, we evaluated Vglut2 haploinsufficient (Vglut2⁺/⁻) mice and their wildtype littermates in a test battery assessing behaviors related to positive, negative and cognitive SCZ symptom domains. We found in Vglut2⁺/⁻ mice an increased locomotor response to amphetamine and an increased sensitivity to the startle-disrupting effects of MK-801, but no impairment in sensorimotor gating. Further on, minor alterations in tests assessing cognitive and negative symptom-related behavior were observed. Possible neurobiological mechanisms of these observations are discussed.

UI MeSH Term Description Entries
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D005260 Female Females
D006948 Hyperkinesis Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders. Hyperactivity, Motor,Hyperkinesia,Hyperkinesia, Generalized,Hyperkinetic Movements,Generalized Hyperkinesia,Generalized Hyperkinesias,Hyperkinesias, Generalized,Hyperkinetic Movement,Motor Hyperactivity,Movement, Hyperkinetic,Movements, Hyperkinetic
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D016291 Dizocilpine Maleate A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects. Dizocilpine,MK-801,MK 801,MK801

Related Publications

Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
March 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
April 2002, Progress in neuro-psychopharmacology & biological psychiatry,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
March 2015, Pharmacology, biochemistry, and behavior,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
December 2005, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
January 1996, Life sciences,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
August 2013, International immunopharmacology,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
January 1989, Life sciences,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
January 1997, Brain research bulletin,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
January 1997, Neurotoxicology,
Arne Naert, and Zsuzsanna Callaerts-Vegh, and Diederik Moechars, and Theo Meert, and Rudi D'Hooge
January 2013, Neurotoxicology and teratology,
Copied contents to your clipboard!